Leenders, A.G.L.J.H. van

prostate model biopsy cancer prostate cancer volume rectal examination screening study dre-based cohort erspc hg pca validation calculator validation cohort examination dre-based rc rectal prostate-speci fic antigen european randomized study antigen rotterdam urology european information presence roobol prostate volume erspc rotterdam risk calculator class outcome curve gleason table volume classes prostate-speci value score dre-based rcs 4 prediction lateralized sextant biopsy prevention /biopsied men development accuracy dre outcome result transrectal ultrasound trial biopsied rcs 4 trus-pv regression analyses pcpt rc analysis 0.69 transrectal randomized stage 577–583 biopsy-detectable 2011 european association 885 pca cases regression population screening 4 yr /biopsied trus-assessed pv schroder fh estimate prostate biopsy erspc rcs 3–5 category prostate-specific antigen dre-estimated volume categories biopsy-detectable prostate cancer erasmus university risk assessment